» Articles » PMID: 15225358

What Should Be the Core Outcomes in Chronic Pain Clinical Trials?

Overview
Publisher Biomed Central
Specialty Rheumatology
Date 2004 Jul 1
PMID 15225358
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

A consensus conference with representatives from academia, governmental agencies, and the pharmaceutical industry met and concluded that clinical trials designed to assess the efficacy and effectiveness of treatments for chronic pain should consider outcomes in six core domains: pain, physical functioning, emotional functioning, patient global ratings of satisfaction, negative health states and adverse events, and patient disposition. In addition, it was acknowledged that there are many secondary domains that might be of importance and should be included in trials depending on the nature of the treatment and population to whom the treatment is targeted.

Citing Articles

Changes in Widespread Pain After Surgical Weight Loss in Racialized Adults: A Secondary Analysis From a 2-Year Longitudinal Study.

Merriwether E, Vanegas S, Curado S, Zhou B, Mun C, Younger O J Pain. 2024; 25(11):104625.

PMID: 39002743 PMC: 11486608. DOI: 10.1016/j.jpain.2024.104625.


Massage for neck pain.

Gross A, Lee H, Ezzo J, Chacko N, Gelley G, Forget M Cochrane Database Syst Rev. 2024; 2:CD004871.

PMID: 38415786 PMC: 10900303. DOI: 10.1002/14651858.CD004871.pub5.


A nigro-subthalamo-parabrachial pathway modulates pain-like behaviors.

Jia T, Wang Y, Chen J, Zhang X, Cao J, Xiao C Nat Commun. 2022; 13(1):7756.

PMID: 36522327 PMC: 9755217. DOI: 10.1038/s41467-022-35474-0.


Efficacy of the Combination of Indomethacin and Methocarbamol versus Indomethacin Alone in Patients with Acute Low Back Pain: A Double-Blind, Randomized Placebo-Controlled Clinical Trial.

Samsamshariat S, Sharifi-Sade M, Zoofaghari S, Maghami Mehr A, Sabzghabaee A J Res Pharm Pract. 2021; 10(2):96-101.

PMID: 34527615 PMC: 8420930. DOI: 10.4103/jrpp.JRPP_21_31.


The Anti-Nociceptive Potential of Tulathromycin against Chemically and Thermally Induced Pain in Mice.

Elbadawy M, Abugomaa A, El-Husseiny H, Mandour A, Abdel-Daim M, Aboelenin S Pharmaceutics. 2021; 13(8).

PMID: 34452208 PMC: 8400808. DOI: 10.3390/pharmaceutics13081247.


References
1.
Bellamy N, Kirwan J, Boers M, Brooks P, Strand V, Tugwell P . Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III. J Rheumatol. 1997; 24(4):799-802. View

2.
Deyo R, Battie M, Beurskens A, Bombardier C, Croft P, Koes B . Outcome measures for low back pain research. A proposal for standardized use. Spine (Phila Pa 1976). 1998; 23(18):2003-13. DOI: 10.1097/00007632-199809150-00018. View

3.
Abbott F, Fraser M . Use and abuse of over-the-counter analgesic agents. J Psychiatry Neurosci. 1998; 23(1):13-34. PMC: 1188892. View

4.
Moher D, Schulz K, Altman D . The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med. 2001; 134(8):657-62. DOI: 10.7326/0003-4819-134-8-200104170-00011. View

5.
Pleis J, Coles R . Summary health statistics for U.S. adults: National Health Interview Survey, 1998. Vital Health Stat 10. 2005; (209):1-113. View